S0003629
Nevirapine 200mg tabs/PAC-60
Nevirapine 200 mg tablets, bottle or blister pack of 60
Indicative Price : Upon Request
NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org
General Description:
Nevirapine 200mg tablets, pack of 60
Technical Specifications:
Each tablet contains Nevirapine 200mg calculated on the anhydrous basis.
Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Standard shelf life:
36 months
Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.
Guidelines for use:
For more details, please click the links listed below:
WHO treatment guidelines
and
WHO Essential Medicines Library
or your regional national guidelines
For details about paediatric dosage schemes, please click the links listed below:
WHO HIV/AIDS
WHO Generic tool for assessing paediatric ARV dosing
Indications:
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral), PO.
Prevention of mother-to-child transmission in HIV-infected patients
Storage:
Do not store above 30ºC (86ºF).
Store in a tightly closed container
Keep out of reach and sight of children.
Dispensing instructions:
Dispense in original container. Do not repack
May be taken with or without regard to food
Regulatory Status:
For latest updates, please click the links listed below:
List of WHO Prequalified Medicines
List of USFDA approved and tentatively approved items
Related Products